Document is current

Any future updates will be listed below

Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies

Crossref DOI link: https://doi.org/10.1208/s12248-017-0082-8

Published Online: 2017-04-25

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark